Glenmark Pharmaceuticals Q3 Results 2025:Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a significant increase in topline by 35.14%, with profit reaching ₹347.96 ...

Launched two decades ago, Glenmark’s Telma brand containing Telmisartan has become a household name for treating hypertension, heart failure, prevention of heart attack and stroke. According to ...

Glenmark Pharmaceuticals Ltd share price was up by 0.40% from the previous closing price of ₹1,373.80. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

Glenmark Pharmaceuticals Q3 Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY. Revenue surged 35% to ₹3,388 crore, with strong growth in ...

This medicine is available only with a doctor's prescription. Do not use Dalacin V Cream if you have an allergy to clindamycin or lincomycin or any of the ingredients in Dalacin V Cream listed at ...

Glenmark Pharmaceuticals Ltd on Friday (February 14) reported a net profit of ₹347.9 crore for Q3FY25, recovering from a net loss of ₹351.3 crore. Revenue from operations surged 35.1% to ₹3,387.6 ...

Glenmark Pharmaceuticals reported a significant profit of Rs 348 crore for Q3 2024, rebounding from a Rs 351 crore loss in the previous year's same quarter. Revenues rose to Rs 3,388 crore. The ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Glenmark Pharmaceuticals and Ireland-based Cosmo Pharmaceuticals NV have received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a product for the treatment of ...

2024 Glenmark Pharmaceuticals Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Third Quar ...

IMO Secretary General Arsenio Dominguez discusses the Red Sea crisis, stating it's a geopolitical issue beyond the organization's control. He emphasizes IMO's focus on safety and security, engaging ...